ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Valsartan-Hydrochlorothiazide Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-12L7033
Home | Market Reports | Health| Pharmacy
Global Valsartan Hydrochlorothiazide Market Insights Forecast to 2028
BUY CHAPTERS

Global Valsartan-Hydrochlorothiazide Market Research Report 2025

Code: QYRE-Auto-12L7033
Report
August 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
TEVA
Lupin Ltd
Aurobindo Pharma
Torrent Pharmaceuticals
Par Pharmaceutical
Huaren Pharmaceutical
Mylan NV
Alembic Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Apotex
Macleods
Chongqing Conquer Pharmaceutical
Beijing Second Pharmaceutical
Cisen Pharmaceutical

Valsartan-Hydrochlorothiazide Market Size

The global market for Valsartan-Hydrochlorothiazide was valued at US$ 589 million in the year 2024 and is projected to reach a revised size of US$ 892 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Valsartan-Hydrochlorothiazide Market

Valsartan-Hydrochlorothiazide Market

This drug is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: valsartan and hydrochlorothiazide. Valsartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a "water pill" (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water.
North American market for Valsartan-Hydrochlorothiazide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Valsartan-Hydrochlorothiazide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Valsartan-Hydrochlorothiazide include Novartis, Teva, Lupin, Aurobindo Pharma, Torrent Pharmaceuticals, Par Pharmaceutical, Huaren Pharmaceutical, Mylan, Alembic Pharmaceuticals, Zhejiang Huahai Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Valsartan-Hydrochlorothiazide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan-Hydrochlorothiazide.
The Valsartan-Hydrochlorothiazide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Valsartan-Hydrochlorothiazide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan-Hydrochlorothiazide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Valsartan-Hydrochlorothiazide Market Report

Report Metric Details
Report Name Valsartan-Hydrochlorothiazide Market
Accounted market size in year US$ 589 million
Forecasted market size in 2031 US$ 892 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Teva, Lupin, Aurobindo Pharma, Torrent Pharmaceuticals, Par Pharmaceutical, Huaren Pharmaceutical, Mylan, Alembic Pharmaceuticals, Zhejiang Huahai Pharmaceutical, APOTEX, MACLEODS, Chongqing Conquer Pharmaceutical, Beijing Second Pharmaceutical, Cisen Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Valsartan-Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Valsartan-Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Valsartan-Hydrochlorothiazide Market growing?

Ans: The Valsartan-Hydrochlorothiazide Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Valsartan-Hydrochlorothiazide Market size in 2031?

Ans: The Valsartan-Hydrochlorothiazide Market size in 2031 will be US$ 892 million.

Who are the main players in the Valsartan-Hydrochlorothiazide Market report?

Ans: The main players in the Valsartan-Hydrochlorothiazide Market are Novartis, Teva, Lupin, Aurobindo Pharma, Torrent Pharmaceuticals, Par Pharmaceutical, Huaren Pharmaceutical, Mylan, Alembic Pharmaceuticals, Zhejiang Huahai Pharmaceutical, APOTEX, MACLEODS, Chongqing Conquer Pharmaceutical, Beijing Second Pharmaceutical, Cisen Pharmaceutical

What are the Application segmentation covered in the Valsartan-Hydrochlorothiazide Market report?

Ans: The Applications covered in the Valsartan-Hydrochlorothiazide Market report are Hospital, Drug Store

What are the Type segmentation covered in the Valsartan-Hydrochlorothiazide Market report?

Ans: The Types covered in the Valsartan-Hydrochlorothiazide Market report are Tablet, Capsule

Recommended Reports

Blood Pressure Therapies

Angiotensin Blockers

Heart Failure & Diuretic

1 Valsartan-Hydrochlorothiazide Market Overview
1.1 Product Definition
1.2 Valsartan-Hydrochlorothiazide by Type
1.2.1 Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.3 Valsartan-Hydrochlorothiazide by Application
1.3.1 Global Valsartan-Hydrochlorothiazide Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Valsartan-Hydrochlorothiazide Market Size Estimates and Forecasts
1.4.1 Global Valsartan-Hydrochlorothiazide Revenue 2020-2031
1.4.2 Global Valsartan-Hydrochlorothiazide Sales 2020-2031
1.4.3 Global Valsartan-Hydrochlorothiazide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Valsartan-Hydrochlorothiazide Market Competition by Manufacturers
2.1 Global Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Valsartan-Hydrochlorothiazide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Valsartan-Hydrochlorothiazide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Product Type & Application
2.7 Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Date of Enter into This Industry
2.8 Global Valsartan-Hydrochlorothiazide Market Competitive Situation and Trends
2.8.1 Global Valsartan-Hydrochlorothiazide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Valsartan-Hydrochlorothiazide Players Market Share by Revenue
2.8.3 Global Valsartan-Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Valsartan-Hydrochlorothiazide Market Scenario by Region
3.1 Global Valsartan-Hydrochlorothiazide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Valsartan-Hydrochlorothiazide Sales by Region: 2020-2031
3.2.1 Global Valsartan-Hydrochlorothiazide Sales by Region: 2020-2025
3.2.2 Global Valsartan-Hydrochlorothiazide Sales by Region: 2026-2031
3.3 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2020-2031
3.3.1 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2020-2025
3.3.2 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2026-2031
3.4 North America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.4.1 North America Valsartan-Hydrochlorothiazide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Valsartan-Hydrochlorothiazide Sales by Country (2020-2031)
3.4.3 North America Valsartan-Hydrochlorothiazide Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.5.1 Europe Valsartan-Hydrochlorothiazide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Valsartan-Hydrochlorothiazide Sales by Country (2020-2031)
3.5.3 Europe Valsartan-Hydrochlorothiazide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valsartan-Hydrochlorothiazide Market Facts & Figures by Region
3.6.1 Asia Pacific Valsartan-Hydrochlorothiazide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Valsartan-Hydrochlorothiazide Sales by Region (2020-2031)
3.6.3 Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.7.1 Latin America Valsartan-Hydrochlorothiazide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Valsartan-Hydrochlorothiazide Sales by Country (2020-2031)
3.7.3 Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
3.8.1 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Valsartan-Hydrochlorothiazide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2020-2031)
4.1.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2020-2025)
4.1.2 Global Valsartan-Hydrochlorothiazide Sales by Type (2026-2031)
4.1.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2020-2031)
4.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2020-2031)
4.2.1 Global Valsartan-Hydrochlorothiazide Revenue by Type (2020-2025)
4.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2026-2031)
4.2.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2020-2031)
4.3 Global Valsartan-Hydrochlorothiazide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2020-2031)
5.1.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2020-2025)
5.1.2 Global Valsartan-Hydrochlorothiazide Sales by Application (2026-2031)
5.1.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2020-2031)
5.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2020-2031)
5.2.1 Global Valsartan-Hydrochlorothiazide Revenue by Application (2020-2025)
5.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2026-2031)
5.2.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2020-2031)
5.3 Global Valsartan-Hydrochlorothiazide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Valsartan-Hydrochlorothiazide Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Valsartan-Hydrochlorothiazide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Company Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Lupin Valsartan-Hydrochlorothiazide Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Company Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Torrent Pharmaceuticals
6.5.1 Torrent Pharmaceuticals Company Information
6.5.2 Torrent Pharmaceuticals Description and Business Overview
6.5.3 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
6.5.5 Torrent Pharmaceuticals Recent Developments/Updates
6.6 Par Pharmaceutical
6.6.1 Par Pharmaceutical Company Information
6.6.2 Par Pharmaceutical Description and Business Overview
6.6.3 Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.6.5 Par Pharmaceutical Recent Developments/Updates
6.7 Huaren Pharmaceutical
6.7.1 Huaren Pharmaceutical Company Information
6.7.2 Huaren Pharmaceutical Description and Business Overview
6.7.3 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.7.5 Huaren Pharmaceutical Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Company Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mylan Valsartan-Hydrochlorothiazide Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Alembic Pharmaceuticals
6.9.1 Alembic Pharmaceuticals Company Information
6.9.2 Alembic Pharmaceuticals Description and Business Overview
6.9.3 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
6.9.5 Alembic Pharmaceuticals Recent Developments/Updates
6.10 Zhejiang Huahai Pharmaceutical
6.10.1 Zhejiang Huahai Pharmaceutical Company Information
6.10.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.10.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.11 APOTEX
6.11.1 APOTEX Company Information
6.11.2 APOTEX Description and Business Overview
6.11.3 APOTEX Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.11.4 APOTEX Valsartan-Hydrochlorothiazide Product Portfolio
6.11.5 APOTEX Recent Developments/Updates
6.12 MACLEODS
6.12.1 MACLEODS Company Information
6.12.2 MACLEODS Description and Business Overview
6.12.3 MACLEODS Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.12.4 MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio
6.12.5 MACLEODS Recent Developments/Updates
6.13 Chongqing Conquer Pharmaceutical
6.13.1 Chongqing Conquer Pharmaceutical Company Information
6.13.2 Chongqing Conquer Pharmaceutical Description and Business Overview
6.13.3 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.13.5 Chongqing Conquer Pharmaceutical Recent Developments/Updates
6.14 Beijing Second Pharmaceutical
6.14.1 Beijing Second Pharmaceutical Company Information
6.14.2 Beijing Second Pharmaceutical Description and Business Overview
6.14.3 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.14.5 Beijing Second Pharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Company Information
6.15.2 Cisen Pharmaceutical Description and Business Overview
6.15.3 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valsartan-Hydrochlorothiazide Industry Chain Analysis
7.2 Valsartan-Hydrochlorothiazide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valsartan-Hydrochlorothiazide Production Mode & Process Analysis
7.4 Valsartan-Hydrochlorothiazide Sales and Marketing
7.4.1 Valsartan-Hydrochlorothiazide Sales Channels
7.4.2 Valsartan-Hydrochlorothiazide Distributors
7.5 Valsartan-Hydrochlorothiazide Customer Analysis
8 Valsartan-Hydrochlorothiazide Market Dynamics
8.1 Valsartan-Hydrochlorothiazide Industry Trends
8.2 Valsartan-Hydrochlorothiazide Market Drivers
8.3 Valsartan-Hydrochlorothiazide Market Challenges
8.4 Valsartan-Hydrochlorothiazide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
TEVA
Lupin Ltd
Aurobindo Pharma
Torrent Pharmaceuticals
Par Pharmaceutical
Huaren Pharmaceutical
Mylan NV
Alembic Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Apotex
Macleods
Chongqing Conquer Pharmaceutical
Beijing Second Pharmaceutical
Cisen Pharmaceutical
List of Tables
 Table 1. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Valsartan-Hydrochlorothiazide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Valsartan-Hydrochlorothiazide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Valsartan-Hydrochlorothiazide Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Valsartan-Hydrochlorothiazide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Valsartan-Hydrochlorothiazide Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Valsartan-Hydrochlorothiazide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Product Type & Application
 Table 12. Global Key Manufacturers of Valsartan-Hydrochlorothiazide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Valsartan-Hydrochlorothiazide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan-Hydrochlorothiazide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Valsartan-Hydrochlorothiazide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Valsartan-Hydrochlorothiazide Sales by Region (2020-2025) & (K Units)
 Table 18. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2020-2025)
 Table 19. Global Valsartan-Hydrochlorothiazide Sales by Region (2026-2031) & (K Units)
 Table 20. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2026-2031)
 Table 21. Global Valsartan-Hydrochlorothiazide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2020-2025)
 Table 23. Global Valsartan-Hydrochlorothiazide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2026-2031)
 Table 25. North America Valsartan-Hydrochlorothiazide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Valsartan-Hydrochlorothiazide Sales by Country (2020-2025) & (K Units)
 Table 27. North America Valsartan-Hydrochlorothiazide Sales by Country (2026-2031) & (K Units)
 Table 28. North America Valsartan-Hydrochlorothiazide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Valsartan-Hydrochlorothiazide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Valsartan-Hydrochlorothiazide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Valsartan-Hydrochlorothiazide Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Valsartan-Hydrochlorothiazide Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Valsartan-Hydrochlorothiazide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Valsartan-Hydrochlorothiazide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Valsartan-Hydrochlorothiazide Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Valsartan-Hydrochlorothiazide Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Valsartan-Hydrochlorothiazide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Valsartan-Hydrochlorothiazide Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Valsartan-Hydrochlorothiazide Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Valsartan-Hydrochlorothiazide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Valsartan-Hydrochlorothiazide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Valsartan-Hydrochlorothiazide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Valsartan-Hydrochlorothiazide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Type (2020-2025)
 Table 51. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Type (2026-2031)
 Table 52. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2020-2025)
 Table 53. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2026-2031)
 Table 54. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2020-2025)
 Table 57. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2026-2031)
 Table 58. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Application (2020-2025)
 Table 61. Global Valsartan-Hydrochlorothiazide Sales (K Units) by Application (2026-2031)
 Table 62. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2020-2025)
 Table 63. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2026-2031)
 Table 64. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Valsartan-Hydrochlorothiazide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2020-2025)
 Table 67. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2026-2031)
 Table 68. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Valsartan-Hydrochlorothiazide Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Valsartan-Hydrochlorothiazide Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Lupin Company Information
 Table 81. Lupin Description and Business Overview
 Table 82. Lupin Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Lupin Valsartan-Hydrochlorothiazide Product
 Table 84. Lupin Recent Developments/Updates
 Table 85. Aurobindo Pharma Company Information
 Table 86. Aurobindo Pharma Description and Business Overview
 Table 87. Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Aurobindo Pharma Valsartan-Hydrochlorothiazide Product
 Table 89. Aurobindo Pharma Recent Developments/Updates
 Table 90. Torrent Pharmaceuticals Company Information
 Table 91. Torrent Pharmaceuticals Description and Business Overview
 Table 92. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product
 Table 94. Torrent Pharmaceuticals Recent Developments/Updates
 Table 95. Par Pharmaceutical Company Information
 Table 96. Par Pharmaceutical Description and Business Overview
 Table 97. Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Par Pharmaceutical Valsartan-Hydrochlorothiazide Product
 Table 99. Par Pharmaceutical Recent Developments/Updates
 Table 100. Huaren Pharmaceutical Company Information
 Table 101. Huaren Pharmaceutical Description and Business Overview
 Table 102. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product
 Table 104. Huaren Pharmaceutical Recent Developments/Updates
 Table 105. Mylan Company Information
 Table 106. Mylan Description and Business Overview
 Table 107. Mylan Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Mylan Valsartan-Hydrochlorothiazide Product
 Table 109. Mylan Recent Developments/Updates
 Table 110. Alembic Pharmaceuticals Company Information
 Table 111. Alembic Pharmaceuticals Description and Business Overview
 Table 112. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product
 Table 114. Alembic Pharmaceuticals Recent Developments/Updates
 Table 115. Zhejiang Huahai Pharmaceutical Company Information
 Table 116. Zhejiang Huahai Pharmaceutical Description and Business Overview
 Table 117. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product
 Table 119. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
 Table 120. APOTEX Company Information
 Table 121. APOTEX Description and Business Overview
 Table 122. APOTEX Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. APOTEX Valsartan-Hydrochlorothiazide Product
 Table 124. APOTEX Recent Developments/Updates
 Table 125. MACLEODS Company Information
 Table 126. MACLEODS Description and Business Overview
 Table 127. MACLEODS Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. MACLEODS Valsartan-Hydrochlorothiazide Product
 Table 129. MACLEODS Recent Developments/Updates
 Table 130. Chongqing Conquer Pharmaceutical Company Information
 Table 131. Chongqing Conquer Pharmaceutical Description and Business Overview
 Table 132. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product
 Table 134. Chongqing Conquer Pharmaceutical Recent Developments/Updates
 Table 135. Beijing Second Pharmaceutical Company Information
 Table 136. Beijing Second Pharmaceutical Description and Business Overview
 Table 137. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product
 Table 139. Beijing Second Pharmaceutical Recent Developments/Updates
 Table 140. Cisen Pharmaceutical Company Information
 Table 141. Cisen Pharmaceutical Description and Business Overview
 Table 142. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product
 Table 144. Cisen Pharmaceutical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Valsartan-Hydrochlorothiazide Distributors List
 Table 148. Valsartan-Hydrochlorothiazide Customers List
 Table 149. Valsartan-Hydrochlorothiazide Market Trends
 Table 150. Valsartan-Hydrochlorothiazide Market Drivers
 Table 151. Valsartan-Hydrochlorothiazide Market Challenges
 Table 152. Valsartan-Hydrochlorothiazide Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Valsartan-Hydrochlorothiazide
 Figure 2. Global Valsartan-Hydrochlorothiazide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Valsartan-Hydrochlorothiazide Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Global Valsartan-Hydrochlorothiazide Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Valsartan-Hydrochlorothiazide Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug Store
 Figure 10. Global Valsartan-Hydrochlorothiazide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Valsartan-Hydrochlorothiazide Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Valsartan-Hydrochlorothiazide Sales (2020-2031) & (K Units)
 Figure 13. Global Valsartan-Hydrochlorothiazide Average Price (USD/Unit) & (2020-2031)
 Figure 14. Valsartan-Hydrochlorothiazide Report Years Considered
 Figure 15. Valsartan-Hydrochlorothiazide Sales Share by Manufacturers in 2024
 Figure 16. Global Valsartan-Hydrochlorothiazide Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Valsartan-Hydrochlorothiazide Players: Market Share by Revenue in Valsartan-Hydrochlorothiazide in 2024
 Figure 18. Valsartan-Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Valsartan-Hydrochlorothiazide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Valsartan-Hydrochlorothiazide Sales Market Share by Country (2020-2031)
 Figure 21. North America Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Valsartan-Hydrochlorothiazide Sales Market Share by Country (2020-2031)
 Figure 25. Europe Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Valsartan-Hydrochlorothiazide Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2020-2031)
 Figure 33. China Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Valsartan-Hydrochlorothiazide Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Valsartan-Hydrochlorothiazide Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Valsartan-Hydrochlorothiazide Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Valsartan-Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Valsartan-Hydrochlorothiazide by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Valsartan-Hydrochlorothiazide by Type (2020-2031)
 Figure 55. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Valsartan-Hydrochlorothiazide by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Valsartan-Hydrochlorothiazide by Application (2020-2031)
 Figure 58. Global Valsartan-Hydrochlorothiazide Price (USD/Unit) by Application (2020-2031)
 Figure 59. Valsartan-Hydrochlorothiazide Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Valsartan Tablets Market Research Report 2024
Valsartan Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Losartan and Hydrochlorothiazide Tablets Market Research Report 2024
Global Valsartan Capsules Market Research Report 2024
lrbesartan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Telmisartan and Hydrochlorothiazide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Candesartan and Hydrochlorothiazide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irbesartan Market Research Report 2024
Global Sartan series Drugs Market Research Report 2024
Valsartan Hydrochlorothiazide Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diltiazem Hydrochloride Extended Release Tablets Market Research Report 2025
Global Irbesartan Tablets Market Insights Forecast to 2030
Global Sacubitril Valsartan API Market Research Report 2025
Global Sartans Market Research Report 2024
Global Chlorothiazide Sodium Injection Market Research Report 2024
Metolazone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Calcium Channel Blockers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hypertension and Heart Failure Drugs Market Insights Forecast to 2030
Global Enalapril Market Research Report 2024
Global Enalaprilat Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions